Even as Congress debates whether to overhaul the nation’s
health care system or to wait for ObamaCare to fail, few lawmakers are talking
about the hidden health care crisis many Americans with health insurance are
already facing: denied coverage.
While much attention has been paid to rising premiums and
pre-existing conditions, a growing number of insured Americans with chronic or
persistent conditions—up to 53 million—risk being denied coverage for
medications, tests and procedures to treat their illness.
I was recently commissioned to conduct a nationwide poll of
insured Americans by the Doctor-Patient Rights Project (DPRP), a new health
care advocacy coalition. The results were alarming and disheartening.
Not only did it find that coverage denials for treatment of
chronic conditions were widespread and common, the results suggest that those
most in need of quality health care—patients treating serious chronic or
persistent diseases—are most frequently denied treatment coverage by their
insurers.
Ironically, these denials worsen the conditions for many
patients and create an even larger health care expense either for the insurance
provider or for the publicly-funded entitlement programs that are intended to
serve those the private insurance system leaves behind.
While the debate over health care reform has focused largely
on increasing the number of people covered by insurance, it has ignored the
burden on taxpayers that occurs when insurance providers withhold treatments to
consumers who have paid for coverage.
DPRP’s poll found that more than 53 million Americans—nearly
one in four with chronic or persistent illnesses—may lack access to essential
treatments because their provider denies coverage.
Many of the denied consumers DPRP surveyed were denied
multiple times and most had to wait more than a month before their insurer
responded to their request for coverage of a prescribed treatment. While they
waited, nearly a third said their condition worsened.
When insurance companies—not doctors—become the arbiters of
patient health, no one should be surprised that cost concerns are prioritized.
Yet even with losses from ObamaCare mandates, health insurance companies’ net
income rose to $13.1 billion in 2016, up 46 percent from the year before…
One tactic, for example, called “therapeutic substitution”
but known more commonly as “non-medical switching” allows insurance companies
to direct pharmacists to dispense a cheaper, alternative drug in lieu of the
medication the doctor prescribed. In many states, it is perfectly legal for
pharmacists to make the switch without notifying the patient or the prescribing
doctor beforehand.
Another cost-saving tactic insurers use is step therapies,
or “fail first” policies, which require patients with a particular condition to
take a less expensive medication and document its ineffectiveness before the
insurer will pay for the more expensive drug treatment the doctor has
prescribed.
In some cases, patients have waited years and been made to
take five or six different drugs before gaining access to the recommended
medication.
As more consumers experience coverage denials, it is
unsurprising that they are rejecting—by wide margins—insurance company
interference in treatment decisions.
DPRP’s poll found that 91 percent of consumers believe
insurance providers should not have the final say in medical decision-making
and should play either a secondary role or no role at all in making treatment
decisions, the largest consensus the survey uncovered.
From a simple economic perspective, consumers who are denied
the coverage they have purchased, and whose conditions deteriorate as a result,
become greater burdens on their health plans or on the taxpayer-funded health
care safety net.
Consequently, Congressional efforts to reform the nation’s
health care system have little chance of succeeding until legislators address
the hidden health care crisis plaguing those who are ostensibly already
covered.
http://www.foxnews.com/opinion/2017/08/21/another-health-care-reform-quandary-what-about-those-who-have-insurance-but-are-still-denied-coverage.html
No comments:
Post a Comment